EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/22/2026
Back to search
Official data from USPTO
HEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
07/23/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/27/2017
Registration date
04/30/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
GAYNOR, BARBARA ANNE
Current location
Historical data usage
Mark description
The mark consists of a shaded circle with a curved line dividing the circle at the bottom. Above the curved line is the design of caterpillar fungus. Below the curved line are the stylized letters "HEC".
Holders and representatives
Holders
Yichang HEC Changjiang Pharmaceutical Co., Ltd.
Representatives
Nazly Aileen Bayramoglu Baryramoglu Law Offices LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorderscancerinflammationdermal diseasesheart diseasesrespiratory diseases and disordersgastrointestinal diseasesinfectious diseasesbone diseasescirculatory diseasecerebral diseases and articular rheumatism; Medicines for human purposesanti-infectives and antivirals; Pharmaceutical preparations for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Pharmaceutical preparationsanti-infectives and antivirals; Pharmaceutical preparations for the treatment of coughcold and flu symptoms; adjuvants for medical purposes; Bulk drug in the nature of a pharmaceutical preparation for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Bulk drug in the nature of a pharmaceutical preparationanti-infectives and antivirals; Bulk drug in the nature of a pharmaceutical preparation for the treatment of hypertensionalzheimer diseasedepressioncancerdiabeteslung diseaseliver diseasecerebral ischemiaprostate diseaseInfertilityrheumatoid arthritisimmune system diseasegastrointestinal disease; Chinese patent medicinesfor use in the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Chinese patent medicinesanti-infectives and antivirals; Chinese patent medicinesfor use in the treatment of traumatic injuriesbleeding woundsgynecological diseasesepistaxisbronchial dilatingpulmonary tuberculosispneumoniagastrointestinal tract hemorrhageanti-inflammationhealing of a woundchilblainhelp healing of fracturemotor impairmentpain from rheumatisminjury of bonesjoints and soft tissuemosquito and insect bitesswelling and pain due to blood stasislumbar muscle strain; Biochemical medicines for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Biochemical medicinesanti-infectives and antivirals; Biochemical medicines for the treatment of pneumoniaurinary tract infectiongynecological infectionsskin and skin structure infectionsmeningitissepticemiacancerdiabetesprostate diseaseInfertilityrheumatoid arthritisimmune system diseasegastrointestinal disease; Medicinal infusions for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Medicinal infusionsanti-infectives and antivirals; Medicinal infusions for the treatment of epilepsyconvulsionsseizurespainmultiple sclerosisneuropathic painspinal cord injurybladder disfunctionperipheral neuropathycancer painperi-operative painrheumatoid arthritisinflammatory bowel diseaseulcerative colitisneurogenic symptomspsychotic disordersdiseases of the central nervous systemstroke and head injurymotion sickness and chemically induced sicknessspasticityoncologycancer symptomspsychiatric illnessesneurodegenerative diseasesobesityobesity associated with type 2 diabetesbulimiaschizophreniacrohn's diseasealzheimer's diseasebone disordershypoxic-ischaemic encephalopathydrugalcohol and nicotine abuse and inflammatory disorders; diagnostic preparations for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; contact lens cleaning preparations; Nutritive substances for microorganisms for medical purposes; disinfectants; food for babies; infant milk powder; depuratives for the body; Veterinary preparations for horsesdogscats for the prevention and treatment of painillnessfatigue; Medicine health bag being medicinal herbs for general health and well-being contained in a small bag; Decoctions for pharmaceutical purposes for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Decoctions for pharmaceutical purposesanti-infectives and antivirals; Decoctions for pharmaceutical purposes for treatment of immune disorders; Drugs for medical purposesfor the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalocularreproductivecirculatorydigestiveearbloodpsychiatricbehavioralnervousimmune system related diseases and disorders; Drugs for medical purposesanti-infectives and antivirals; Medical hemostatic paste; medicinal herbs; Transdermal patches for use in the temporary relief of headache and muscle pain; medicinal tea; Allergy capsules; soporifics; Biological preparations for medical purposesfor the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Biological preparations for medical purposesanti-infectives and antivirals; medical preparations for slimming purposes; medicinal wine; poultices; Medicine casesportablefilledfirst aid kits; Medicinal oil; Liquid medicines for the treatment of digestive system disorderscardiovascular disordersnervous system disordersmetabolic system disorders and dermal diseases; Liquid medicinesanti-infectives and antivirals; Liquid medicines for treating colds; Medicines for veterinary purposes for treating and preventing infections caused by bacteria or parasites in companion and food producing animals; surgical dressings; solutions for contact lenses
Publications
History of USPTO decisions and trademark events.
43 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/21/2025
71AG
REGISTERED-SEC.71 ACCEPTED
07/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/15/2025
ES71
TEAS SECTION 71 RECEIVED
04/21/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/30/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/11/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/16/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
08/16/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/18/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/18/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NPUB
NOTICE OF PUBLICATION
01/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/17/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2018
ALIE
ASSIGNED TO LIE
12/13/2018
NREV
NOTICE OF REVIVAL - MAILED
12/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2018
PETG
PETITION TO REVIVE-GRANTED
12/10/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
12/10/2018
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
10/11/2018
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
10/11/2018
RFNT
REFUSAL PROCESSED BY IB
03/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/15/2018
RFRR
REFUSAL PROCESSED BY MPU
03/15/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2018
CNRT
NON-FINAL ACTION WRITTEN
03/09/2018
DOCK
ASSIGNED TO EXAMINER
03/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/15/2018
Continuous trademark protection
Get notified about every new filing that threatens HEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.